AstraZeneca CEO Pascal Soriot on Thursday unveiled ambitious plans to launch 15 new drugs by 2030 — and he’s wasting no time, with 30 Phase III trial initiations planned this year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,